Starting 8/18: Find what you need using new Epic Chart Search feature.
- New Therapy Plans available for use for non-chemotherapy standing orders that occur repeatedly over multiple visits.
- View Referral Records from Media Tab in Chart Review.
- New and updated CT orders.
Starting 9/4: Patients with active MyHealth account to receive message regarding influenza vaccine.
Update on Ebola Virus Disease (EVD)
As of August 6, 2014, the US Centers for Disease Control (CDC) activated a Level 1 response in recognition of the public health threat posed by the Ebola outbreak in West Africa. The countries specifically affected at this point include Guinea, Liberia, Sierra Leone and Nigeria. Activation of a Level 1 response is a direct response to the public health emergency primarily with in the above named countries and allows CDC to marshal additional resources to help coordinate a world-wide effort to halt the spread of EVD. This is not a response to a specific risk of Ebola within the United States.
It is possible that cases of EVD may be imported into the US, beyond the two known cases of US citizens brought to Atlanta, by persons returning to the US from the affected countries. SHC has deployed several safe guards to allow staff to appropriately respond to and care for any patients suspected of having EVD throughout Stanford Health Care. Appropriate and rapid identification of possible cases is of paramount importance to ensure that patients are cared for under the right circumstances. We are following guidance from CDC and the California Department of Public Health in terms of case identification. Transmission occurs through direct contact with blood or body fluids of infected individuals or through contact with items or surfaces contaminated with body fluids. Suspected EVD patients will be placed in contact and droplet isolation: airborne isolation will be added if an aerosol generating procedure is to be performed. Additional information regarding detailed procedures may be found online in the Infection Control Manual. Please contact Infection Prevention and Control at pager #16167 for any suspected cases of EVD.
Submit an article to firstname.lastname@example.org